higenamine has been researched along with Hypoxia-Ischemia, Brain in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, KC; Ha, YM; Kim, HJ; Kim, MY; Kim, YM; Lee, JH; Lee, YS; Park, MK | 1 |
1 other study(ies) available for higenamine and Hypoxia-Ischemia, Brain
| Article | Year |
|---|---|
Higenamine reduces HMGB1 during hypoxia-induced brain injury by induction of heme oxygenase-1 through PI3K/Akt/Nrf-2 signal pathways.
Topics: Alkaloids; Animals; Apoptosis; Apoptosis Regulatory Proteins; Cell Hypoxia; Cell Survival; Cells, Cultured; Chromones; Enzyme Induction; Heme Oxygenase (Decyclizing); HMGB1 Protein; Hypoxia-Ischemia, Brain; Infarction, Middle Cerebral Artery; Male; Morpholines; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidative Stress; Peroxidase; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Signal Transduction; Tetrahydroisoquinolines | 2012 |